Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by Razoriuson Jan 03, 2016 8:51pm
267 Views
Post# 24426575

RE:Cystic Fibrosis and Vertex

RE:Cystic Fibrosis and VertexJust for clarification regarding Vertex, CF, & gene therapy:

The current Vertex medications available on market are not "gene therapy".

However, Vertex is trying to get involved with fundamental research aimed at CF gene therapy. (not yet clinical study trials & not close - still some time to go) .

For CF patients, there is some hope for a cure due to some 'limited success" in new breakthrough gene therapy approaches (not involving Vertex) but unfortunately this is still many trials & years away.

Gene therapy, in general, is more complicated than it seems.

As mentioned by saltaja, PLI aims to treat some CF side effects.

GLTA
Bullboard Posts